News & Events
September 30, 2019
The Critical Path for Parkinson’s Consortium (CPP) welcomes PMD Alliance as newest memberThe Critical Path for Parkinson’s Consortium (CPP) is thrilled to welcome the PMD Alliance (Parkinson & Movement Disorder Alliance) as our newest member. The PMD Alliance is an independent, national nonprofit organization that provides opportunities for people impacted by Parkinson’s and other movement disorders to learn, live life more fully, and connect with others. Their...
August 12, 2019
C-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting ScientistC-Path’s Critical Path for Parkinson’s Consortium (CPP) is pleased to welcome Linda L. Restifo, MD, PhD, as a Visiting Scientist. Currently a Professor of Neurology at the University of Arizona College of Medicine – Tucson, Dr. Restifo is a neurogeneticist with broad interests in translational medicine. She will be using her expertise to help CPP...
June 19, 2019
The Critical Path for Parkinson’s consortium announces C-Path’s Data Sharing Pioneer Award recipientsThe Critical Path for Parkinson’s consortium (CPP) is pleased to announce the following recipients as the first to receive C-Path’s Data Sharing Pioneer Award. This award is bestowed to member organizations and advisors who have demonstrated dedicated commitment to sharing patient-level data for inclusion in our integrated Parkinson’s database. The database is fundamental to CPP’s...
March 18, 2019
C-Path President and CEO, Board Director Selected to Serve on Esteemed National Academies of Sciences, Engineering and Medicine CommitteeC-Path President and CEO Martha Brumfield, PhD, and C-Path Board Director Alastair J. Wood, MD, FRCP, have both been selected to the serve on the National Academy Consensus Committee examining Mutual Recognition Agreements in the Regulation of Medicines under The National Academies of Sciences, Engineering and Medicine. Dr. Wood will serve as chair. An ad...
January 4, 2019
At the IBD Biomarker Summit, Hosted by the Crohn’s & Colitis Foundation, C-Path Shares the Case for formation of an IBD Biomarker ConsortiumAt the IBD Biomarkers Summit, hosted by the Crohn’s & Colitis Foundation on October 17-18, 2018, in Newark, N.J., Critical Path Institute (C-Path) highlighted the need for an Inflammatory Bowel Disease (IBD) focused consortium with the goal to qualify biomarkers as tools to support IBD drug development programs. The two-day participatory event featured presentations and...